CVS Health Corporation (NYSE:CVS) Belonging to the Retail-Wholesale sector which declined -0.63% and closed its last trading session at $88.99.
The company reported its last EPS on 6/30/2016 and is expected to report its next EPS on 11/4/2016. Currently, the stock has a 1 Year Price Target of $110.93.
The consensus recommendation, according to Zacks Investment research, is 1.47. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 1.47 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.47 and 1.5 respectively.
CVS Health Corporation on 6/30/2016 reported its EPS as $1.32 with the analysts projecting the EPS of the stock as $1.3. The company beat the analyst EPS Estimate with the difference of $0.02. This shows a surprise factor of 1.5%.
Many analysts have provided their estimated foresights on CVS Health Corporation Earnings, with 22 analysts believing the company would generate an Average Estimate of $1.57. Whereas they predicted High and Low Earnings Estimate as $1.59 and $1.55 respectively. While in the same Quarter Previous year, the Actual EPS was $1.28.
Analysts are also projecting an Average Revenue Estimate for CVS Health Corporation as $45.29 Billion in the Current Quarter. This estimate is provided by 20 analysts. The High Revenue estimate is predicted as 45.59 Billion, while the Low Revenue Estimate prediction stands at 45.03 Billion. The company’s last year sales total was 38.64 Billion.
For the Current Quarter, the growth estimate for CVS Health Corporation is 22.7%, while for the Next Quarter the stock growth estimate is 17%. In the past 5 years, the stock showed growth of 14.63% per annum. While for the next 5 years, the growth estimate is 14.58%.
The Company got Downgrade by Morgan Stanley on 20-Jun-16 from Overweight to Equal-Weight.
Insider Trades for CVS Health Corporation show that the latest trade was made on 18 May 2016 where Swift (Richard J), the Director completed a transaction type “Buy” in which 612 shares were traded at a price of $100.95.
6 Insider Sales transactions were made totaling 148037 shares traded.
22 analysts projected Price Targets for CVS Health Corporation. The analysts believe that the company stock price could grow as high as $123. The Low Price target projection by analysts is $73.99 and the Mean Price Target is $110.93.
CVS Health Corporation (NYSE:CVS) has the market capitalization of $95.48 Billion. The company rocked its 52-Week High of $106.67 on May 9, 2016 and touched its 52-Week Low of $86.5 on Feb 9, 2016. The stock has Return on Assets (ROA) of 5.2 percent. Return on Equity (ROE) stands at 13.2% and Return on Investment (ROI) of 9.4 percent.
The stock is currently showing YTD performance of -7.79 Percent. The company has Beta Value of 0.83 and ATR value of 1.22. The Weekly and Monthly Volatility stands at 1.11% and 1.22%.
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.